drugset / Trial / NCT07136103
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
RandomizedSequentialTriple-blindBasic science
Summary
The objective of this study is to evaluate the safety, tolerability, immunogenicity and pharmacokinetics (PK ) properties following a single dose of ABBV-277 in healthy adult participants.
Timeline
- Start
- 2025-08-19
- Primary completion
- 2026-06-11
- Completion
- 2026-06-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-277 | Unknown | — | Intravenous |
Indications
No indication recorded.